drugset / Trial / NCT06327932
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
Phase 3
Not yet recruiting
320 enrolled
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine the efficacy and safety of Hyperthermic Intravesical Chemotherapy (HIVEC) with Gemcitabine (GEM) after Transurethral Resection of Bladder Tumors (TURBT) in the treatment of medium or high-risk group Non-Muscle-Invasive Bladder Cancer (NMIBC).
Timeline
- Start
- 2024-04-01
- Primary completion
- 2026-03-31
- Completion
- 2028-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 3 g | Other |